GlassScriptPhysician profile
Frank Congiusta
NPI 1245280403
$81,690.05
in general payments reported to CMS, 2019-2025
19 companies · $2,936 in 2025
The $2,936 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,579 · 2020: $16K · 2021: $42K · 2022: $10K · 2023: $1,621 · 2024: $4,949 · 2025: $2,936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,880 · Consulting Fee: $2,540 · Travel and Lodging: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,879.89 |
| Consulting Fee | $2,540.00 |
| Travel and Lodging | $1,086.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Techmah Medical, LLC | $42,666.06 | 2020-2022 | |
| Convatec INC. | $9,962.10 | 2019-2025 | |
| Depuy Synthes Products, INC. | $8,511.57 | 2021 | |
| Medical Device Business Services, INC. | $8,450.85 | 2019-2024 | Actis, Velys |
| Zimmer Biomet Holdings, INC. | $4,389.18 | 2019-2025 | Avenir, Z1 Hip System, Persona |
| Depuy Synthes Sales INC. | $2,770.76 | 2019-2025 | Velys, Attune, Actis |
| Stryker Corporation | $2,420.70 | 2019-2025 | Mako, Axsos, Variax |
| Lima USA, INC. | $1,565.68 | 2019-2022 | |
| Smith+Nephew, INC. | $327.68 | 2019-2024 | Journey II |
| Innovation Technologies INC | $132.96 | 2022-2023 | Irrisept |
| Medacta USA, INC. | $107.79 | 2021 | |
| Heraeus Medical, LLC. | $94.05 | 2019-2025 | Palacos |
| Encore Medical, LP | $84.83 | 2023 | Djo Surgical |
| Ferring Pharmaceuticals INC. | $63.53 | 2022 | |
| Prodigy Surgical Distribution, INC. | $60.83 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $36.95 | 2020-2025 | Exparel |
| E.R. Squibb & Sons, L.L.C. | $17.19 | 2019 | |
| Ethicon US, LLC | $14.74 | 2021 | |
| Pfizer INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Congiusta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.